FDA Approves CEVIMELINE HYDROCHLORIDE — Zydus Lifesciences Limited

# FDA Approves Zydus Lifesciences' Generic Cevimeline Hydrochloride Zydus Lifesciences Limited has received FDA approval for its generic cevimeline hydrochloride oral formulation, potentially expanding treatment access for patients with dry mouth conditions while pressuring pricing in the salivary stimulant market. The approval is expected to introduce competitive generic pricing alternatives to branded cevimeline products, benefiting both patients and healthcare payers seeking cost-effective therapeutic options.